Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a small backend update with no changes to the trial information shown on the page.
    Difference
    0.1%
    Check dated 2026-08-11T17:14:08.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor version update to the page, likely for maintenance.
    Difference
    0.1%
    Check dated 2026-07-28T10:58:26.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing v3.6.0. This indicates a minor update to the page template or rendering without affecting the study details or user-visible information.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The study page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and introduces a Last verified metadata label, while existing labels such as Verified, Last known status was:, Intervention / Treatment, and Revision have been removed or renamed. These changes reorganize the page's structure and metadata without modifying the underlying study information or eligibility criteria.
    Difference
    2%
    Check dated 2026-06-15T18:53:17.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5 on the Study Record, reflecting a minor page update. No substantive study content or eligibility details appear to be changed.
    Difference
    0.1%
    Check dated 2026-06-08T15:18:52.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4 replacing the previous Revision: v3.5.3. This indicates a minor system update rather than changes to study data on the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:27:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.